Search results
Jump to navigation
Jump to search
- ...hors = Piletz JE, Halaris A, Ernsberger PR | title = Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression | journal = C {{Imidazoline receptor modulators}} ...7 KB (880 words) - 08:15, 28 March 2025
- ...gonist]] and a weak [[Alpha-1 adrenergic receptor|α<sub>1</sub> adrenergic receptor]] agonist.{{cn|date=May 2019}} {{Adrenergic receptor modulators}} ...7 KB (873 words) - 20:00, 29 May 2025
- ...cox GL | title = Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice | journal = The Journal of ...[[imidazoline receptor]] subtype 1 (I<sub>1</sub>).<ref name=Monox/> This receptor subtype is found in both the rostral ventro-lateral pressor and ventromedia ...10 KB (1,261 words) - 23:57, 19 June 2025
- ...-HT2A receptor|5-HT<sub>2A</sub>]] and [[5-HT2C receptor|5-HT<sub>2C</sub> receptor]]s, partially substitutes for the psychedelic DOM in rodents, inhibits [[ac | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || >10,000 (rat/human) ...20 KB (2,622 words) - 19:52, 23 June 2025
- | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 200–270 || Human | [[5-HT1B receptor|5-HT<sub>1B</sub>]] || 1415 || Human ...18 KB (2,268 words) - 21:26, 18 May 2025
- | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || >10,000 | [[5-HT1B receptor|5-HT<sub>1B</sub>]] || >10,000 ...20 KB (2,383 words) - 23:08, 17 June 2025
- ...lic]]; [[Hallucinogen]]; [[Serotonin]] [[5-HT2A receptor|5-HT<sub>2A</sub> receptor]] [[agonist]] | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 1,678–>5,600 ...21 KB (2,522 words) - 03:16, 8 June 2025
- ...| number = 2731471 | inventor = Synerholm M, Jules LH, Sahyun M | title = Imidazoline Derivatives | gdate = 17 January 1956 | assign1 = Sahyun Laboratories | pos There is no antidote for tetryzoline or other similar imidazoline analogue poisoning, but the [[Symptomatic treatment|symptoms can be allevia ...14 KB (1,928 words) - 10:21, 31 May 2025
- ...DA2018/> It is an [[alpha-2A adrenergic receptor|α<sub>2A</sub>-adrenergic receptor]] agonist.<ref name=FDA2018/> It was approved for use by the [[Food and Dru ...these two drugs are paired, naltrexone is administered to induce an opioid receptor blockade, sending the subject into immediate withdrawal and accelerating th ...15 KB (2,039 words) - 21:22, 29 May 2025
- | class = α1 and α2 [[Adrenergic receptor agonist]],<br>[[Decongestant]] ...ntry=US|number=2868802A|title=2-(γ-TERT-BUTYL-O,O'-DIMETHYL-PHENYL-METHYL)-IMIDAZOLINE AND SALTS|status=patent|pubdate=|fdate=1957-06-11|pridate=1956-07-10|gdate= ...14 KB (1,846 words) - 22:35, 29 May 2025
- ...="PDSP">{{cite web|url=https://pdsp.unc.edu/databases/pdsp.php?receptorDD=&receptor=&speciesDD=&species=&sourcesDD=&source=&hotLigandDD=&hotLigand=&testLigandD | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 50–59 || ↓ || Human || ...28 KB (3,505 words) - 15:24, 23 June 2025
- The drug acts as a [[serotonin]] [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[agonist]].<ref name="Ray2010" /><ref name="RudinLuethiHoener2022" /> | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 2,550–7,904 ...28 KB (3,407 words) - 12:33, 25 May 2025
- | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || >10,000 | [[5-HT1B receptor|5-HT<sub>1B</sub>]] || {{Abbr|ND|No data}} ...38 KB (4,982 words) - 02:18, 29 June 2025
- ...gic receptor|α<sub>1</sub> adrenergic receptors]] and [[Alpha-2 adrenergic receptor|α<sub>2</sub> adrenergic receptors]], most notably.<ref name="PubChem"/> On ...and, partially, [[Alpha-2 adrenergic receptor|α<sub>2</sub>]] [[adrenergic receptor]]s.<ref name="adrenomimetic">{{cite book | vauthors = Westfall TC, Westfall ...16 KB (2,033 words) - 03:22, 4 June 2025
- ...delic]]; [[Hallucinogen]]; [[Serotonin]] [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[agonist]]; [[Anti-inflammatory agent]] ...ed in [[scientific research]] in the study of psychedelics and [[serotonin receptor]]s.<ref name="GlennonDukat2024" /><ref name="CanalMorgan2012" /> ...33 KB (4,304 words) - 19:50, 27 June 2025
- ...s an [[agonist]] of [[alpha-2 adrenergic receptor|α<sub>2</sub>-adrenergic receptor]]s in certain parts of the brain.<ref name="Cormack2005" /> It was develope ...thors = Giovannitti JA, Thoms SM, Crawford JJ | title = Alpha-2 adrenergic receptor agonists: a review of current clinical applications | journal = Anesthesia ...34 KB (4,198 words) - 22:48, 14 June 2025
- ...delic]]; [[Hallucinogen]]; [[Serotonin]] [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[agonist]] | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 3,656–14,200 (K<sub>i</sub>)<br />12,800–13,900 ({{A ...38 KB (4,789 words) - 13:30, 31 May 2025
- | class = [[Alpha-2 adrenergic receptor|α<sub>2A</sub>-adrenergic receptor agonist]] ...mong others, is an [[Alpha-2 adrenergic receptor|α<sub>2A</sub>-adrenergic receptor agonist]]<ref name="Goodman13">{{cite book| vauthors = Westfall TC, Macarth ...63 KB (7,959 words) - 13:13, 9 June 2025
- ...erotonergic psychedelic]]; [[Serotonin]] [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[agonist]]; [[Antidepressant]]; [[Psychic energizer]]; [[Cognitive enhan ...HT2B receptor|5-HT<sub>2B</sub>]], and [[5-HT2C receptor|5-HT<sub>2C</sub> receptor]]s.<ref name="LuethiRudinHoener2022" /><ref name="Ray2010" /> ...55 KB (6,874 words) - 23:55, 17 June 2025
- | class = [[Alpha-2 adrenergic receptor|α<sub>2A</sub>-adrenergic receptor agonist]] ...d-Release Tablets (Intuniv), a Nonstimulant Selective Alpha(2A)-Adrenergic Receptor Agonist For Attention-Deficit/Hyperactivity Disorder |journal=P & T |volume ...48 KB (6,280 words) - 10:25, 15 June 2025